We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

    • Androgen receptor

    Health

    New Platinum Complex Shows Promise in Treating Advanced Prostate Cancer

    A recent study published in Inorganic Chemistry reveals a promising new approach to prostate cancer treatment using azolato-bridged dinuclear platinum(II) complexes. Led by researchers from Shibaura Institute of Technology, the study highlights the potential of the compound 5-H-Y to effectively target prostate cancer cells with reduced toxicity compared to traditional cisplatin. This innovative therapy could transform treatment options for advanced prostate cancer patients, offering hope for improved outcomes and minimized side effects.

    Posted on Jhon
    Health

    New Insights into Drug-Resistant Prostate Cancer

    New research from the University of Eastern Finland sheds light on combatting drug-resistant prostate cancer by targeting the glucocorticoid receptor. Limiting the activity of coregulator proteins could prevent the development of drug resistance, offering potential new treatment strategies for this challenging cancer type.

    Posted on Jhon